A Pilot Randomised Control Trial Exploring the Feasibility and Acceptability of Delivering a Personalised Modular Psychological Intervention for Anxiety Experienced by Autistic Adults: Personalised Anxiety Treatment-Autism (PAT-A).
Anxiety is commonly experienced by autistic people and impacts on quality of life and social participation. New anxiety interventions are required to effectively meet the needs of autistic people. Personalised Anxiety Treatment-Autism (PAT-A©) is a bespoke, modular approach to treating anxiety in up...
| Publicado en: | Journal of Autism & Developmental Disorders Vol. 54; no. 11; pp. 4045 - 4061 |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Nov2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180153900&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 180153900 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01623257 AUT jtl: Journal of Autism & Developmental Disorders issn: 01623257 maglogo: N pubinfo: dt: Nov2024 vid: 54 iid: 11 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 180153900 172039345 180153900 180153900 10.1007/s10803-023-06112-5 180153900 ppf: 4045 ppct: 16 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: A Pilot Randomised Control Trial Exploring the Feasibility and Acceptability of Delivering a Personalised Modular Psychological Intervention for Anxiety Experienced by Autistic Adults: Personalised Anxiety Treatment-Autism (PAT-A). aug: au: Rodgers, Jacqui Brice, Samuel Welsh, Patrick Ingham, Barry Wilson, Colin Evans, Gemma Steele, Katie Cropper, Emily Le Couteur, Ann Freeston, Mark Parr, Jeremy R. affil: https://ror.org/01kj2bm70 Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK sug: subj: Individualized Medicine Patient Centered Care Psychosocial Intervention Anxiety Therapy Autism Spectrum Disorder Psychosocial Factors Persons with Disabilities Psychosocial Factors National Health Programs United Kingdom Treatment Outcomes Human Funding Source England Pilot Studies Randomized Controlled Trials Random Assignment Adult United Kingdom Anxiety Evaluation Quality of Life Evaluation Descriptive Statistics Psychoeducation After Care Thematic Analysis Interviews Cognitive Therapy Adult: 19-44 years ab: Anxiety is commonly experienced by autistic people and impacts on quality of life and social participation. New anxiety interventions are required to effectively meet the needs of autistic people. Personalised Anxiety Treatment-Autism (PAT-A©) is a bespoke, modular approach to treating anxiety in up to 12 sessions. This study explored the feasibility and acceptability of delivering PAT-A© in the UK National Health Service (NHS). A single-blind randomised controlled trial design. Thirty-four autistic adults were recruited via clinical services and randomised to receive either PAT-A© or enhanced treatment as usual (CCSP). Outcome assessments relating to anxiety, quality of life and related constructs were completed at baseline, immediately post intervention; and at 3 and 12 months. Seventy-one percent of the PAT-A© group and 65% of the CCSP met diagnostic threshold for at least three anxiety disorders. Retention was good across both groups, with 82% (N = 14/17) completing the full course of PAT-A© and 71% (N = 12/17) attending both psychoeducational sessions in CCSP. 94% in PAT-A© and 82% in CCSP completed some follow up assessment 3 months post-intervention. Thematic analysis of interview data revealed that many participants valued the personalised approach, developed transferable skills and experienced positive changes to their anxiety. Participants were willing to be recruited and randomised, PAT-A© was feasible to deliver in the NHS and the trial methods and materials were acceptable. Our findings indicate that a fully powered clinical and cost-effectiveness trial of PAT-A© is warranted. pubtype: Academic Journal doctype: research tables/charts randomized controlled trial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|